Hôpital Purpan

Toulouse 31300

0 studies enrolling now · 11 studies all time

What they study most

Acute Stroke, Alzheimer Disease, Cerebral Ischemia, Cervical Dystonia, Chronic Myelomonocytic Leukemia, Compensated Cirrhosis, Indolent Systemic Mastocytosis, MDS, Myelodysplastic Syndromes, Nonalcoholic Steatohepatitis, RAEB, SARS-CoV2 Infection

Studies at this site

• A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke — Completed
• Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer — Completed
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis — Completed
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
• Phase IV-Cervical Dystonia-INTEREST IN CD2 — Completed
• Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts — Completed
• Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis — Completed
• A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma — Stopped early
• Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients — Stopped early
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients — Stopped early